Management of Anticoagulants and Antithrombotics in Patients With CSDH
NCT ID: NCT05079295
Last Updated: 2022-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2021-02-20
2024-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma
NCT03582293
Coagulopathy on the First Postoperative Day Predicts the Long-term Survival of Traumatic Brain Injury Patients
NCT04322721
Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma
NCT03280212
Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation
NCT06696079
Correlation Between Reticulated Platelets and Major Adverse Cardiac and Cerebrovascular Events After Noncardiac Surgery
NCT02097602
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Patients taking anticoagulants or antithrombotics
CSDH evacuation
Burr hole for chronic subdural hematomas
Group 2
Controls
CSDH evacuation
Burr hole for chronic subdural hematomas
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CSDH evacuation
Burr hole for chronic subdural hematomas
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent
* Evidence of CSDH which needs surgery
* patients taking antithrombotics or anticoagulants
Exclusion Criteria
18 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital of Ferrara
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dott.ssa Alba Scerrati
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Sant'Anna
Ferrara, Emilia-Romagna, Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1102/2020/Oss/AOUFe
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.